Targeting the enhancer of zeste homologue 2 in medulloblastoma-Reference-Cited by-同舟云学术

Targeting the enhancer of zeste homologue 2 in medulloblastoma

Published:2012-07-30 Issue:8 Volume:131 Page:1800-1809
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Alimova Irina,Venkataraman Sujatha,Harris Peter,Marquez Victor E.,Northcott Paul A.,Dubuc Adrian,Taylor Michael D.,Foreman Nicholas K.,Vibhakar Rajeev

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Medulloblastoma;Dhall;J Child Neurol,2009

2. Management of and prognosis with medulloblastoma: therapy at a crossroads;Packer;Arch Neurol,2008

3. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma;Mulhern;J Clin Oncol,2005

4. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols;Dhall;Pediatr Blood Cancer,2008

5. Medulloblastoma comprises four distinct molecular variants;Northcott;J Clin Oncol,2011

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma;Cancers;2023-12-15

2. Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy;Current Molecular Pharmacology;2023-12-05

3. The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined Therapies;Cancers;2023-07-30

4. Epigenetics and immune cells in medulloblastoma;Frontiers in Genetics;2023-03-10

5. A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis;Nature Cell Biology;2023-02-27